ARTICLE | Company News
RaQualia, Maruho in deal for sodium channel blocker
January 5, 2018 10:45 PM UTC
RaQualia Pharma Inc. (JASDAQ:4579) granted Maruho Co. Ltd. (Osaka, Japan) exclusive, worldwide rights to develop and commercialize an undisclosed selective sodium channel blocker. RaQualia will rece...